DelMar Pharmaceuticals Inc. (DMPI)
Symbol Info
Listed Symbol DMPI
Name DelMar Pharmaceuticals Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2019-06-30
Latest Fiscal Revenue $-
Latest Fiscal EPS $-3.26
Price Info
21 Day Moving Average $0.5024
21 Day EMA $0.512160
50 Day Moving Average $0.6698
50 Day EMA $0.737310
200 Day EMA $2.387100
200 Day Moving Average 2.408530
52 Week High $7.00
52 Week Low $0.40
52 Week Change $-92.523100
Alpha -0.041720
Beta 1.2676
Standard Deviation 0.258806
R2 0.028293
Periods 60
Share Information
10 Day Average Volume 314,108
20 Day Average Volume 228,686
30 Day Average Volume 254,998
50 Day Average Volume 553,227
Outstanding Shares 11,388,483
Float Shares 9,904,464
Percent Float 86.97%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 10
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months -
Institute Holdings Percent 0.800000
Institute Sold Previous 3 Months -
Insider Holdings Date 2019-08-31
Insider Bought Previous 3 Months -
Insider Holdings Percent 17.00%
Insider Sold Previous 3 Months -
Insiders Shares Owned 1,484,019
Price Change
7 Day Price Change $0.0810000
7 Day Percent Change 20.00%
21 Day Price Change $-0.0461
21 Day Percent Change -8.66%
30 Day Price Change $-0.129
30 Day Percent Change -20.98%
Month To Date Price Change $-0.0669
Month To Date Percent -12.10%
90 Day Price Change $-0.864
90 Day Percent Change -64.00%
Quarter To Date $-0.0669
Quarter To Date Percent -12.10%
180 Day Price Change $-3.176
180 Day Percent Change -86.73%
200 Day Price Change $-4.42532
200 Day Percent Change -90.10%
Year To Date $-2.933
Year To Date Percent -85.79%
Profile
Description DelMar Pharmaceuticals Inc is a clinical and commercial-stage drug development company, which focuses on the research and development of drugs for the treatment of cancer. The company's principal product candidate includes VAL-083, a small-molecule chemotherapeutic agent, which is in clinical trials stage for the treatment of refractory glioblastoma multiforme, a form of brain cancer. It also has a strategic collaboration with Guangxi Wuzhou Pharmaceutical for the development of VAL-083 used in treating chronic myelogenous leukemia and lung cancer. All the business activity of the firm is functioned through the region of Canada.
Details
Issue Type CS
Market Cap $5,534,803
Sec Type EQS
Auditor Ernst & Young LLP
Total Shares Outstanding 11,388,483
CEO Saiid Zarrabian
Employees 2
Last Audit UQ
Classification
CIK 0001498382
Industry Biotechnology
Sector Healthcare
NAICS HMO Medical Centers(621491)
Info
Address 12707 High Bluff Drrive
Suite 200
San Diego, CA 92130
Website https://www.delmarpharma.com
Facisimile
Telephone +1 858 350-4364
Email ir@delmarpharma.com
Key Ratios
Profitability
EBIT Margin -
EBITDA Margin -
Pre-Tax Profit Margin -
Profit Margin Cont -
Gross Margin -
Profit Margin TOT -
Income Statements
Revenue $-
Revenue Per Share $-
Revenue 3 Years $-
Revenue 5 Years $-
Valuation Measures
PE Ratio -
Enterprise Value $7,555,768
Price To Sales -
Price To Free Cash -1.4
PE High Last 5 Years -
Price To Book 10.2
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book -2
Financial Strength
Total Debt To Equity -
Int Coverage -
Current Ratio 1.9
Leverage Ratio -1.3
Quick Ratio 1.8
Long Term Debt To Capital -
Assets
Receivables Turnover -
Invoice Turnover -
Assets Turnover -
Management Effectiveness
Return Assets -146.3
Return On Equity 406.38
Return On Capital -
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type Stock
Your Recent History
NASDAQ
DMPI
DelMar Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20191022 08:36:55